NEW YORK – With Joseph Biden, Jr., poised to become the next president of the United States, laboratories and diagnostic firms began planning for an administration switch that could change ...
NEW YORK ─ Shares of several in vitro diagnostic companies plummeted on Monday following an announcement that a vaccine developed by Pfizer and BioNTech demonstrated 90 percent efficacy in a clinical ...
This article has been updated to include comments sent by Innova to 360Dx on Friday. NEW YORK — The US Food and Drug Administration on Thursday requested that Innova Medical Group stop sales of its ...
NEW YORK – Historically focused on clinical sequencing, Fulgent Genetics recently saw dramatic increases in its COVID-19 RT-qPCR testing business. While the firm plans to continue to grow its PCR ...
NEW YORK – Opko Health's BioReference Laboratories on Thursday announced an agreement with Major League Baseball to provide COVID-19 testing for the 2021 season. The Elmwood Park, New Jersey-based ...
This article has been updated to clarify that Pelican's test is a rapid antigen diagnostic. NEW YORK – Canary Global subsidiary Pelican Diagnostics said on Monday that it has received a CE mark for ...
NEW YORK – Becton Dickinson will collaborate with Scanwell Health to develop an at-home rapid test for SARS-CoV-2, the firms said on Monday. Financial terms of the collaboration were not disclosed.
NEW YORK – In an effort to help alleviate pandemic-related sample prep bottlenecks, researchers at the National Institutes of Health have developed a direct-from-sample testing protocol utilizing a ...
NEW YORK — Slovakian researchers have completed a study looking at the impact of population-wide rapid antigen testing on the prevalence of SARS-CoV-2 in that country and found that mass testing with ...
NEW YORK – After receiving the first ever Emergency Use Authorization for a SARS-CoV-2 breath test from the US Food and Drug Administration, InspectIR is planning out its next steps toward ...
NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Siemens Healthineers' Atellica IM SARS-CoV-2 IgG (sCOVG) antibody test. The chemiluminescent ...
NEW YORK — Canadian healthcare firm Switch Health said on Wednesday that it has partnered with Anven Biosciences to develop a new class of artificial antibodies for use in point-of-care SARS-CoV-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results